PTC Therapeutics adds Morgan Stanley healthcare banking veteran Jessica Chutter to board

Filed March 25, 2026 · Period ending March 24, 2026 · ~1 min read

Key Changes

• medium

  Jessica Chutter, former Vice Chair of Healthcare Investment Banking at Morgan Stanley with 40+ years of experience, appointed to board effective March 24, 2026 as Class I director with term expiring at 2026 annual meeting.

  Item 5.02 verify on EDGAR →
• low

  Chutter received initial equity grant of 3,475 stock options (vesting monthly over 36 months) and 4,000 RSUs (vesting annually over 3 years), plus pro-rated 2026 annual grant of 2,896 options and 3,333 RSUs.

  Item 5.02 verify on EDGAR →
• low

  New director will receive standard $50,000 annual cash retainer plus travel expense reimbursement, consistent with existing outside director compensation policy.

  Item 5.02 verify on EDGAR →